STMN1 and ovarian carcinoma: This inconsistency may be attributed to two factors: first, the microarrays of ovarian cancer used for IHC comprised various subtypes of ovarian cancer tissues, and STMN1 expression levels differed significantly among these subtypes (Figure H, I).